Dipòsit Digital de Documents de la UAB
Publication
Artículo científico (JournalArticle)
Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma
The online version of this article (10.1007/s00018-019-03041-4) contains supplementary material, which is available to authorized users., Current therapies for most non-infectious diseases are directed at or affect functionality of the human translated genome, barely 2% of all genetic information. By contrast, the therapeutic potential of targeting the transcriptome, ~ 70% of the genome, remains largely unexplored. RNA therapeutics is an emerging field that widens the range of druggable targets and includes elements such as microRNA. Here, we sought to screen for microRNA with tumor-suppressive functions in neuro-blastoma, an aggressive pediatric tumor of the sympathetic nervous system that requires the development of new therapies. We found miR-323a-5p and miR-342-5p to be capable of reducing cell proliferation in multiple neuroblastoma cell lines in vitro and in vivo, thereby providing a proof of concept for miRNA-based therapies for neuroblastoma. Furthermore, the combined inhibition of the direct identified targets such as CCND1, CHAF1A, INCENP and BCL-XL could reveal new vulnerabilities of high-risk neuroblastoma.
Project:
Ministerio de Educación FPU16-01099
,
Cultura y Deporte CP11-00052
,
Instituto de Salud Carlos III CP16-00006
,
Instituto de Salud Carlos III PI14-00561
,
Instituto de Salud Carlos III PI14-00647
,
Instituto de Salud Carlos III PI17-00564
,
Instituto de Salud Carlos III RD12-0036-0016
,
Instituto de Salud Carlos III 2014/SGR-660